User profiles for C. Henri van Werkhoven

CH (Henri) van Werkhoven

Assistant professor, University Medical Center Utrecht, the Netherlands
Verified email at umcutrecht.nl
Cited by 3999

Algorithm-based care versus usual care for the early recognition and management of complications after pancreatic resection in the Netherlands: an open-label …

…, BA Zonderhuis, LA Daamen, CH van Werkhoven… - The Lancet, 2022 - thelancet.com
Background Early recognition and management of postoperative complications, before they
become clinically relevant, can improve postoperative outcomes for patients, especially for …

Impact of complications after pancreatoduodenectomy on mortality, organ failure, hospital stay, and readmission: analysis of a nationwide audit

…, ME Verweij, LA Daamen, CH van Werkhoven… - Annals of …, 2022 - journals.lww.com
… Because grade B/C delayed gastric emptying by definition occurs 8–14 days after
pancreatic resection, including patients who died within this time period might cause an …

[HTML][HTML] Early COVID-19 vaccine effectiveness of XBB. 1.5 vaccine against hospitalisation and admission to intensive care, the Netherlands, 9 October to 5 December …

CH van Werkhoven, AW Valk, B Smagge… - …, 2024 - eurosurveillance.org
We present early vaccine effectiveness (VE) estimates of the 2023 seasonal COVID-19 XBB.1.5
vaccine against COVID-19 hospitalisation and admission to an intensive care unit (ICU) …

Care after pancreatic resection according to an algorithm for early detection and minimally invasive management of pancreatic fistula versus current practice …

…, JM Schreinemakers, F Wit, CH Van Werkhoven… - Trials, 2020 - Springer
Background Pancreatic resection is a major abdominal operation with 50% risk of postoperative
complications. A common complication is pancreatic fistula, which may have severe …

[HTML][HTML] Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled …

…, MJM Bonten, CHH van Werkhoven… - Clinical Microbiology …, 2023 - Elsevier
Objectives To test whether Bacillus Calmette-Guérin (BCG) vaccination would reduce the
incidence of COVID-19 and other respiratory tract infections (RTIs) in older adults with one or …

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022

…, C van Roekel, J Pijpers, CHH van Werkhoven… - Vaccine, 2023 - Elsevier
Background We aimed to estimate vaccine effectiveness (VE) against COVID-19 mortality,
and to explore whether an increased risk of non-COVID-19 mortality exists in the weeks …

Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases

…, CH van Werkhoven… - Clinical …, 2022 - clinicalmicrobiologyandinfection …
Background Emerging infectious diseases are a growing threat, through population growth,
increased trade and travel, urbanization, deforestation, and climate change [

[HTML][HTML] Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022

…, MJ Knol, HE de Melker, CHH van Werkhoven… - Vaccine, 2023 - Elsevier
Background Vaccines against COVID-19 have proven effective in preventing COVID-19
hospitalisation. In this study, we aimed to quantify part of the public health impact of COVID-19 …

Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial

…, J de Vos-Geelen, CH van Werkhoven… - JAMA …, 2024 - jamanetwork.com
Importance Implementation of new cancer treatment strategies as recommended by
evidence-based guidelines is often slow and suboptimal. Objective To improve the implementation …

An obituary on DAV-132—authors' viewpoint on the current limits of pivotal trials in clinical microbiome research

…, L Timbermont, CH Van Werkhoven - Journal of …, 2023 - academic.oup.com
7 Manichanh C, Grenot P, Gautheret-Dejean A et al. Susceptibility of human herpesvirus 6 to
antiviral compounds by flow cytometry analysis. Cytometry 2000; 40: 135–40. https://doi. org…